The NSF SBIR program is designed to encourage small businesses to develop innovative solutions that have the potential to make significant societal and economic impacts. Envivo Bio is honored to have been selected for this grant, which will enable the company to accelerate the development of CapScan and bring it to market.
CapScan is an ingestible gut sampling devices that promises to advance human gut microbiome research. The grant will enable Envivo Bio to further develop the technology and conduct necessary research and development, including testing and prototyping, to move the project towards commercialization.
“We are thrilled to receive this grant from the National Science Foundation,” said Dari Shalon, PhD, founder and CEO of Envivo Bio and the inventor of CapScan. “This award will allow us to continue our work on CapScan intestinal sampling device, which has the potential to shed new light on the human gut microbiota. We look forward to working with the NSF and other partners to bring this innovation to the market and make a meaningful impact on society.”
